查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1593907

MRI显影剂市场：按产品、给药途径、应用和最终用户 - 全球预测 2025-2030

MRI Contrast Media Agents Market by Product (Paramagnetic Contrast Agents, Supermagnetic Contrast Agent), Route of Administration (Injection, Oral), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年MRI显影剂市场规模为25亿美元，预计2024年将达26.7亿美元，复合年增长率为7.54%，2030年将达到41.6亿美元。

MRI显影剂是用于提高磁振造影(MRI) 扫描品质并可以更准确地诊断和评估医疗状况的特殊试剂。这些钆基药物改变水分子的磁性，提高内部结构、组织和异常的可见度。这些试剂的需求源自于诊断过程中对高解析度成像的需求，特别是用于检测肿瘤、发炎和血管疾病。应用广泛应用于神经病学、心臟病学、肿瘤学和肌肉骨骼成像。最终用途主要是医院、诊断影像中心和研究机构。

主要市场统计
基准年[2023] 25亿美元
预测年份 [2024] 26.7亿美元
预测年份 [2030] 41.6亿美元
复合年增长率（%） 7.54%

由于慢性病的增加、MRI 技术的进步以及对微创诊断程序的需求不断增长，MRI显影剂市场正在蓬勃发展。此外，人口老化和医疗保健支出的增加正在推动市场成长。开发非钆基药物和新製剂的机会很多，有望使肾功能不全或过敏患者轻鬆排泄。为了利用这些优势，公司应该投资于旨在提高安全性和扩大应用范围的研发活动。

然而，挑战仍然存在，包括严格的监管要求、高昂的影像处理成本以及有关钆保留的安全问题。来自电脑断层扫描等替代显像模式和人工智慧影像分析等新技术的竞争也可能阻碍成长。此外，在某些地区，先进的 MRI 技术的使用受到限制，从而限制了市场的扩张。

在技​​术创新方面，生物分解性和显影剂显影剂的探索提供了一条充满希望​​的道路。专注于减少副作用和增强目标特异性的研究也可能推动成长。复杂的监管环境要求市场相关人员适应不断变化的指导方针，以维持合规性和市场地位。总体而言，该市场即将成长，但充分发挥其潜力需要在技术、经济和监管挑战之间进行策略性导航。

市场动态：揭示快速发展的 MRI显影剂市场的关键市场洞察

供需的动态交互作用正在改变 MRI显影剂市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病盛行率上升
    • 诊断中心和医院数量的增加
    • 显影剂的核准增加
  • 市场限制因素
    • MRI显影剂高成本
  • 市场机会
    • 采用技术先进的 MRI显影剂
    • 提高早期诊断意识
  • 市场问题
    • 低度开发国家难以获得先进治疗

波特五力：驾驭 MRI显影剂市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解 MRI显影剂市场的外部影响

外部宏观环境因素在塑造 MRI显影剂市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解 MRI显影剂市场的竞争格局

对 MRI显影剂市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：MRI显影剂市场供应商的绩效评估

FPNV定位矩阵是评估MRI显影剂市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製 MRI显影剂市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对 MRI显影剂市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病盛行率上升
      • 诊断中心和医院的增加
      • 显影剂的核准增加
    • 抑制因素
      • MRI显影剂成本高
    • 机会
      • 采用技术先进的 MRI显影剂
      • 提高早期诊断意识
    • 任务
      • 在开发中国家获得先进治疗方法的困难
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 MRI显影剂市场：副产品

  • 介绍
  • 顺磁性显影剂
    • 血池显影剂
    • 细胞外液
    • 器官特异性药物
  • 超磁显影剂

第七章 MRI显影剂市场：依给药途径

  • 介绍
  • 注射
  • 口服

第八章 MRI显影剂市场：依应用分类

  • 介绍
  • 胃肠道
  • 肝胆系统
  • 静脉
  • 神经影像诊断

第 9 章 MRI显影剂

  • 介绍
  • 门诊手术中心
  • 诊断中心
  • 医院

第10章 美洲MRI显影剂市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区MRI显影剂市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲MRI显影剂市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Acro Lifesciences（I）Pvt. Ltd.
  • Bayer AG
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Bracco Imaging SpA
  • Daiichi Sankyo Company, Limited
  • General Electric Company
  • Guerbet SA
  • iMAX Diagnostic Imaging Limited
  • Lantheus Medical Imaging, Inc.
  • Miltenyi BIoTec BV & Co. KG
  • Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd.
  • SANOCHEMIA Pharmazeutika GmbH
  • Spago Nanomedical AB
  • Trivitron Healthcare
  • Vitalquan, LLC
Product Code: MRR-F927BA46208C

The MRI Contrast Media Agents Market was valued at USD 2.50 billion in 2023, expected to reach USD 2.67 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 4.16 billion by 2030.

MRI contrast media agents are specialized drugs used to enhance the quality of magnetic resonance imaging (MRI) scans, enabling more accurate diagnosis and assessment of medical conditions. These agents, primarily gadolinium-based, alter the magnetic properties of water molecules, improving the visibility of internal structures, tissues, and abnormalities. Their necessity stems from the need for high-resolution images in diagnostic procedures, particularly for detecting tumors, inflammation, and vascular disease. Application-wise, they are extensively utilized in neurology, cardiology, oncology, and musculoskeletal imaging. End-use primarily spans hospitals, diagnostic imaging centers, and research institutions.

KEY MARKET STATISTICS
Base Year [2023] USD 2.50 billion
Estimated Year [2024] USD 2.67 billion
Forecast Year [2030] USD 4.16 billion
CAGR (%) 7.54%

The market for MRI contrast media agents is buoyed by increasing incidences of chronic diseases, advancements in MRI technology, and growing demand for minimally invasive diagnostic procedures. Additionally, the aging population and rising healthcare expenditure are driving market growth. Opportunities abound in the development of non-gadolinium-based agents and novel formulations that promise easier excretion, catering to patients with renal impairment or allergies. To capitalize on these, businesses should invest in R&D activities aimed at enhancing safety profiles and broadening application scopes.

However, challenges persist, such as stringent regulatory requirements, high costs of imaging procedures, and safety concerns related to gadolinium retention. Competition from alternative imaging modalities, like CT scans, and emerging technologies, such as AI-driven imaging analyses, could also hamper growth. Moreover, certain regions face limited access to advanced MRI technology, constraining market expansion.

For innovation, exploration into biodegradable and non-metallic contrast agents presents a promising avenue. Research focusing on reducing adverse reactions and enhancing target specificity could also spur growth. The intricate regulatory landscape necessitates that market players stay aligned with evolving guidelines to maintain compliance and market presence. Overall, the market is poised for growth but requires strategic navigation amidst technological, economic, and regulatory challenges to fully harness its potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving MRI Contrast Media Agents Market

The MRI Contrast Media Agents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic disorders
    • Growing number of diagnostic centers and hospitals
    • Increasing approvals of contrast agents
  • Market Restraints
    • High cost of MRI contrast media agents
  • Market Opportunities
    • Introduction of technologically advanced MRI contrast agents
    • Increasing awareness regarding early diagnosis
  • Market Challenges
    • Inaccessibility of advanced therapeutics in underdeveloped countries

Porter's Five Forces: A Strategic Tool for Navigating the MRI Contrast Media Agents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the MRI Contrast Media Agents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the MRI Contrast Media Agents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the MRI Contrast Media Agents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the MRI Contrast Media Agents Market

A detailed market share analysis in the MRI Contrast Media Agents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the MRI Contrast Media Agents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the MRI Contrast Media Agents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the MRI Contrast Media Agents Market

A strategic analysis of the MRI Contrast Media Agents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the MRI Contrast Media Agents Market, highlighting leading vendors and their innovative profiles. These include Acro Lifesciences (I) Pvt. Ltd., Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., Bracco Imaging S.p.A, Daiichi Sankyo Company, Limited, General Electric Company, Guerbet SA, iMAX Diagnostic Imaging Limited, Lantheus Medical Imaging, Inc., Miltenyi Biotec B.V. & Co. KG, Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd., SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Trivitron Healthcare, and Vitalquan, LLC.

Market Segmentation & Coverage

This research report categorizes the MRI Contrast Media Agents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Paramagnetic Contrast Agents and Supermagnetic Contrast Agent. The Paramagnetic Contrast Agents is further studied across Blood Pool Contrast Agents, Extracellular Fluid Agents, and Organ-Specific Agents.
  • Based on Route of Administration, market is studied across Injection and Oral.
  • Based on Application, market is studied across Gastrointestinal, Hepatobiliary, Intravenous, and Neurological Imaging.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic disorders
      • 5.1.1.2. Growing number of diagnostic centers and hospitals
      • 5.1.1.3. Increasing approvals of contrast agents
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of MRI contrast media agents
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of technologically advanced MRI contrast agents
      • 5.1.3.2. Increasing awareness regarding early diagnosis
    • 5.1.4. Challenges
      • 5.1.4.1. Inaccessibility of advanced therapeutics in underdeveloped countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. MRI Contrast Media Agents Market, by Product

  • 6.1. Introduction
  • 6.2. Paramagnetic Contrast Agents
    • 6.2.1. Blood Pool Contrast Agents
    • 6.2.2. Extracellular Fluid Agents
    • 6.2.3. Organ-Specific Agents
  • 6.3. Supermagnetic Contrast Agent

7. MRI Contrast Media Agents Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injection
  • 7.3. Oral

8. MRI Contrast Media Agents Market, by Application

  • 8.1. Introduction
  • 8.2. Gastrointestinal
  • 8.3. Hepatobiliary
  • 8.4. Intravenous
  • 8.5. Neurological Imaging

9. MRI Contrast Media Agents Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Diagnostic Centers
  • 9.4. Hospitals

10. Americas MRI Contrast Media Agents Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific MRI Contrast Media Agents Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa MRI Contrast Media Agents Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acro Lifesciences (I) Pvt. Ltd.
  • 2. Bayer AG
  • 3. Beijing Beilu Pharmaceutical Co., Ltd.
  • 4. Bracco Imaging S.p.A
  • 5. Daiichi Sankyo Company, Limited
  • 6. General Electric Company
  • 7. Guerbet SA
  • 8. iMAX Diagnostic Imaging Limited
  • 9. Lantheus Medical Imaging, Inc.
  • 10. Miltenyi Biotec B.V. & Co. KG
  • 11. Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd.
  • 12. SANOCHEMIA Pharmazeutika GmbH
  • 13. Spago Nanomedical AB
  • 14. Trivitron Healthcare
  • 15. Vitalquan, LLC

LIST OF FIGURES

  • FIGURE 1. MRI CONTRAST MEDIA AGENTS MARKET RESEARCH PROCESS
  • FIGURE 2. MRI CONTRAST MEDIA AGENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MRI CONTRAST MEDIA AGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MRI CONTRAST MEDIA AGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MRI CONTRAST MEDIA AGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MRI CONTRAST MEDIA AGENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY BLOOD POOL CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY EXTRACELLULAR FLUID AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ORGAN-SPECIFIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY SUPERMAGNETIC CONTRAST AGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY HEPATOBILIARY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY NEUROLOGICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. MRI CONTRAST MEDIA AGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. MRI CONTRAST MEDIA AGENTS MARKET, FPNV POSITIONING MATRIX, 2023